CA
ADVM

Commerzbank Aktiengesellschaft’s Adverum Biotechnologies ADVM Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,174
Closed -$48K – 970
2016
Q3 		$48K Buy
+1,174
New +$44.5K ﹤0.01% 900

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Commerzbank Aktiengesellschaft's ADVM Position: Q4 2016 in Review

Commerzbank Aktiengesellschaft sold out of Adverum Biotechnologies (ADVM) in Q4 2016, closing a stake of 1,174 shares — an estimated $48K sold.

Commerzbank Aktiengesellschaft first reported a position in ADVM in Q3 2016 and held it in 1 quarter. The position peaked at $48K in Q3 2016. 83 funds tracked by Wall St. Rank hold ADVM as of Q4 2016.

  • Commerzbank Aktiengesellschaft reported no remaining Adverum Biotechnologies position as of Q4 2016 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 1,174 Adverum Biotechnologies shares in Q4 2016, an estimated $48K.
  • Commerzbank Aktiengesellschaft first reported a position in Adverum Biotechnologies in Q3 2016 and held it in 1 quarter.
  • Commerzbank Aktiengesellschaft's Adverum Biotechnologies position peaked at $48K in Q3 2016.
  • 83 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2016.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2016, filed 7 Feb 2017.